|
|
||||||||
The Journal of Immunology, Vol 158, Issue 2 741-747, Copyright © 1997 by American Association of Immunologists
ARTICLES |
S Hoshino, I Kukimoto, K Kontani, S Inoue, Y Kanda, F Malavasi and T Katada
Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
We reported that 1) ecto-NAD+ glycohydrolase (NADase) activity induced upon differentiation of HL-60 cells is localized on the extracellular carboxyl-terminal side of CD38 and that 2) CD38 ligation by specific mAbs is followed by protein tyrosine phosphorylation in the cells. The strategy selected for identifying the relevant catalytic domains of the molecule relies upon the production in COS-7 cells of carboxyl-terminal deletion mutants of CD38. The mutants with fewer than 15 amino acids deleted at the carboxyl terminus of the 300-amino acid wild-type molecule maintained NADase activity, whereas those with more than 27 amino acids deleted did not. The general inference is that the carboxyl- terminal 273-285 sequence bears the site of enzyme activity. Introduction of site-directed mutation of a conserved cysteine residue (Cys275), located in the 273-285 sequence, completely abolished NADase activity. The second issue resolved in this work is the definition of an epitope of the agonistic anti-CD38 mAbs. To this aim, a panel of selected anti-CD38 mAbs was tested using these mutants and various CD38 fragments as the target in immunoblot analyses. All of the epitopes recognized by mAbs inducing protein tyrosine phosphorylation were mapped on an identical site containing the carboxyl-terminal sequence of 273-285. The conclusion is that the discrete carboxyl-terminal sequence identified in the present study not only plays a key role in its ecto-NADase activity, but actually constitutes the epitopes exploited by the agonistic anti-CD38 mAbs for transmembrane signaling.
This article has been cited by other articles:
![]() |
F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A. L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology Physiol Rev, July 1, 2008; 88(3): 841 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mallone, E. Ortolan, G. Baj, A. Funaro, S. Giunti, E. Lillaz, F. Saccucci, M. Cassader, P. Cavallo-Perin, and F. Malavasi Autoantibody Response to CD38 in Caucasian Patients With Type 1 and Type 2 Diabetes: Immunological and Genetic Characterization Diabetes, April 1, 2001; 50(4): 752 - 762. [Abstract] [Full Text] |
||||
![]() |
F. G. S. de Toledo, J. Cheng, M. Liang, E. N. Chini, and T. P. Dousa ADP-Ribosyl Cyclase in Rat Vascular Smooth Muscle Cells : Properties and Regulation Circ. Res., June 9, 2000; 86(11): 1153 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zubiaur, M. Guirado, C. Terhorst, F. Malavasi, and J. Sancho The CD3-gamma delta epsilon Transducing Module Mediates CD38-induced Protein-tyrosine Kinase and Mitogen-activated Protein Kinase Activation in Jurkat T Cells J. Biol. Chem., July 16, 1999; 274(29): 20633 - 20642. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Borrione, S. Peola, S. Mariani, B. Besostri, R. Mallone, F. Malavasi, A. Pileri, and M. Massaia CD38 Stimulation Lowers the Activation Threshold and Enhances the Alloreactivity of Cord Blood T Cells by Activating the Phosphatidylinositol 3-Kinase Pathway and Inducing CD73 Expression J. Immunol., May 15, 1999; 162(10): 6238 - 6246. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Franco, L. Guida, S. Bruzzone, E. Zocchi, C. Usai, and A. D. Flora The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes FASEB J, November 1, 1998; 12(14): 1507 - 1520. [Abstract] [Full Text] |
||||
![]() |
M. Konopleva, Z. Estrov, S. Zhao, M. Andreeff, and K. Mehta Ligation of Cell Surface CD38 Protein with Agonistic Monoclonal Antibody Induces a Cell Growth Signal in Myeloid Leukemia Cells J. Immunol., November 1, 1998; 161(9): 4702 - 4708. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morra, M. Zubiaur, C. Terhorst, J. Sancho, and F. Malavasi CD38 is functionally dependent on the TCR/CD3 complex in human T cells FASEB J, May 1, 1998; 12(7): 581 - 592. [Abstract] [Full Text] |
||||
![]() |
A. Funaro, M. Reinis, O. Trubiani, S. Santi, R. Di Primio, and F. Malavasi CD38 Functions Are Regulated Through an Internalization Step J. Immunol., March 1, 1998; 160(5): 2238 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, M. Morra, R. Mallone, C. M. Ausiello, E. Prager, G. Garbarino, U. Dianzani, H. Stockinger, and F. Malavasi Human CD38 (ADP-Ribosyl Cyclase) Is a Counter-Receptor of CD31, an Ig Superfamily Member J. Immunol., January 1, 1998; 160(1): 395 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Zilber, S. Gregory, R. Mallone, S. Deaglio, F. Malavasi, D. Charron, and C. Gelin CD38 expressed on human monocytes: A coaccessory molecule in the superantigen-induced proliferation PNAS, March 14, 2000; 97(6): 2840 - 2845. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |